Pre-eclampsia refers to recent onset of hypertensive (Systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure ≥ 90mm Hg) & proteinuria (≥ 0.3 gm protein in 24 hours urine specimen) after 20 weeks of gestation. [11] It is considered to be severe if SBP> 160 or ≥ 110mm Hg DBP or proteinuria ≥ 5gm in a 24 hours urine specimen or oliguria, cerebral or visual disturbances, pulmonary edema, impaired liver function or thrombocytopenia is present. There is an appreciable variation in the proportion of maternal mortality due to these disordered between the low & high income group, maximally noted to occur in the low-middle income countries. [11] Hence based on above condition the present study was planned for Assessment of Maternal and Fetal Outcomes in Pre-Eclampsia Condition in Females from Bihar Region. The present study was planned in Department of Obstetrics and Gynaecology, Mangalam Nursing Home, Nawada, Bihar. In the present study 20 females suffered from the Pre-eclampsia condition were enrolled. The comparative study was done by enrolling normal pregnant females without any complication. All information regarding demographic profile, antenatal care, clinical finding, laboratory findings were noted. Seizures were controlled by using Magnesium Sulfate as per the Pritchard regimen. Delivery of the patient was the definitive treatment. The outcome of both, the mother and her newborn was traced till discharge or death. The data generated from the present study concludes that maternal and newborn deaths due to preeclampsia are preventable: by increasing community awareness about the condition, improving antenatal care quality, and scaling up proven best practices to prevent mild preeclampsia’s escalation to severe pre-eclampsia. By detecting and managing pre-eclampsia, judiciously, thus preventing eclampsia, can improve the survival rate of women and babies in developing countries.